Publication

Byline

Bengaluru daycare horror: Capgemini does not bear direct liability, says Karnataka child rights group

New Delhi, July 4 -- The Karnataka State Commission for Protection of Child Rights (KSCPCR) said on Saturday that Capgemini, at the centre of the case pertaining to the "abuse" of toddlers at its dayc... और पढ़ें


Rangpur faces heat stress amid climate shift; power cuts worsen public suffering

Rangpur, July 4 -- The weather pattern in the Rangpur region is gradually changing due to the impact of climate change. Although the monsoon season is ongoing, intense heat similar to the month of Bh... और पढ़ें


Are natural sweeteners like honey, jaggery, and maple syrup better than refined sugar?

New Delhi, July 4 -- For generations, our grandmothers reached for honey, jaggery, or molasses instead of refined sugar. Their wisdom wasn't just rooted in tradition; it was backed by nature. In today... और पढ़ें


MHA designates 23 Pakistan-based individuals linked to JeM, LeT as terrorists under UAPA

New Delhi, July 4 -- The Union home ministry has designated 23 individuals based in Pakistan, associated with Jaish-e-Mohammad (JeM), Lashkar-e-Taiba (LeT) and other outfits, as "terrorists" under the... और पढ़ें


Indonesia aims ATMP Hub for Asia-Pacific

Jakarta, July 4 -- Indonesia is aiming to become an Asia-Pacific hub for Advanced Therapy Medicinal Products (ATMP) by expanding the clinical application of stem cell therapy through the implementatio... और पढ़ें


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... और पढ़ें


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... और पढ़ें


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... और पढ़ें


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... और पढ़ें


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... और पढ़ें